Latest Innovation News

Beam Communications reports a pivotal FY25 marked by the divestment of its Zoleo joint venture, unlocking significant capital and delivering improved margins despite a statutory revenue decline. The company projects positive operating cash flow and growth in FY26.

Rhythm Biosciences has formalised a strategic co-marketing partnership with the Know Your Lemons Foundation to promote its geneType Breast Cancer Risk Assessment Test, expanding access to early detection tools for women in the US and Australia.

Starpharma has received a $3.7 million R&D Tax Incentive refund for the 2025 financial year, reinforcing its commitment to advancing dendrimer technology and biotechnology innovation in Australia.

Dicker Data has reported a robust first half of FY25, with revenue climbing 15.7% driven by AI-related deals and an accelerated PC refresh cycle. The company raised its full-year guidance, signaling confidence despite ongoing market challenges.

Tetratherix Limited advances its Tetramatrix biomaterial platform with a robust IP portfolio, scalable manufacturing, and strategic partnerships aimed at commercialising across multiple clinical franchises.

RAS Technology Holdings reports a robust 31% revenue increase in FY25, marking its second consecutive profitable year, driven by strategic acquisitions and global partnerships that position it for sustained growth.

MoneyMe Limited reported a robust FY25 with a $1.6 billion loan book, 28% growth from FY24, and a $24 million operating cash profit, signaling a strong turnaround. The fintech lender also improved credit quality and expanded funding capacity, setting the stage for future growth.

MONEYME Limited reported a robust FY25 with a 28% increase in its loan book to $1.6 billion and a positive operating cash profit of $24 million, underpinned by improved credit quality and strategic funding initiatives.

X2M Connect reports a 43% revenue decline in FY25 but improves gross margins and expands into the Middle East and renewable energy sectors, setting a positive outlook for FY26.

MoneyMe Limited posted a statutory net loss of $66.6 million for FY25, driven by accounting adjustments and credit loss provisions despite strong loan book growth and funding advances. The company is poised for growth with a new credit card launch and ongoing AI integration.

dorsaVi appoints Mathew Regan as Group CEO to spearhead commercialisation of next-gen RRAM-enabled AI and robotics technologies, aiming for global expansion.

SomnoMed delivered a strong FY25 performance with revenue climbing 22% to $111.5 million and EBITDA turning positive at $9.2 million, boosted by operational improvements and FDA clearance of its Rest Assure device. The company projects further growth in FY26 with expanded manufacturing and ongoing innovation.